FuKPNeuHC: Azlocillin and mezlocillin: New ureidopenicillins. Antimicrob Agents Chemother19:532–533, 1981.
2.
WhiteGWMalowJBZimelisVMPahlavanzadeHPanwalkerAPJacksonGG: Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother15:540–543, 1979.
3.
WrightAJWilkowskiCJ: The penicillins. Mayo Clin Proc58:21–32, 1983.
4.
TjandramagaTBMullieAVerbessetRde SchepperPJVerbistL: Piperacillin: Human pharmacokinetics after intravenous and intramuscular administration. Antimicrob Agents Chemother14:829–837, 1978.
5.
MeyersBRHirschmanSZStrougoLSrulevitchE: Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Antimicrob Agents Chemother17:608–611, 1980.
6.
BerganTBrodwallEKWiik-LarsonE: Mezlocillin pharmacokinetics in patients with normal and impaired renal functions. Antimicrob Agents Chemother16:651–654, 1979.
7.
MangioneABondinotFOSchultzRMJuskoWJ: Dose dependent pharmacokinetics of mezlocillin in relation to renal impairment. Antimicrob Agents Chemother21:428–435, 1982.
8.
BaskerMJEdmondsonRAESutherlandR: Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin, and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes. Infection7:67–73, 1979.
9.
WhiteARComberKRSutherlandR: Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother18:182–189, 1980.
10.
NeuHC: Progress in antibiotic research and development of monoclonal antibodies. Infect Dis13:4–21, 1983.
